The increased IL-10 following rKVAC85B administration therefore not only underscores the potential of rKVAC85B as an effective component of TB vaccines but also highlights the importance of further investigating the mechanisms by which this vaccine modulates immune responses. Here, IL10 is linked to tuberculosis.